Delivery Order SPE2DB22D2206-SPE2DB24FFH33
- Not listed
- This federal contract award, valued at $11,679.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG inhalers, a pharmaceutical product used for the treatment of respiratory conditions. This is a firm-fixed-price delivery order contract with a completion date of February 13, 2024. The contract was awarded on an open competition basis, with no set-aside designations....
- This federal contract award for $1,765.63 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product Advair HFA 115-21 MCG Inhaler, 12 GM. The contract is a Firm Fixed Price Delivery Order with a period of performance through April 29, 2024. This contract award is not associated with a set-aside and was procured through full and open competition. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) under a Delivery Order valued at $6,654.52. The contract provides for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a period of performance through February 28, 2024. The contract is a Firm Fixed Price type and was awarded without a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $17,822.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 7, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a...
- This federal contract award, valued at $2,801.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of an Advair HFA 115-21 MCG Inhaler, a pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The $25,074.96 firm fixed-price delivery order contract has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award, valued at $1,598.73, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 1, 2024. This delivery order contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $37,257.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM, with a completion date of February 23, 2024. This contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,030.68 firm fixed-price delivery order is for the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG inhalers. The $1,688.82 firm-fixed-price contract has an ultimate completion date of August 17, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFH33Delivery Order
This federal contract award, valued at $13,318.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, which is a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 1/27/24 |